Posts in tag

codeine


AJP takes a look back over the events of 2015, a turbulent year in the history of community pharmacy “May you live in interesting times,” is purportedly an ancient Chinese …

The Australian Self Medication Industry has today welcomed the announcement by the TGA of a further consultation regarding scheduling of OTC codeine medicines. “The TGA’s proposed amendments take a more …

The TGA is seeking further advice and submissions from stakeholders in regard to newly proposed options for the future scheduling of OTC codeine-containing preparations. Last month it deferred its final …

The TGA decision to defer the rescheduling of codeine-containing OTC medications conflicts with rising codeine analgesics misuse, its devastating consequences and the recognition that opioid misuse is a public health …

The deferral of a decision on codeine scheduling will give the Guild time to address the problem of codeine dependence, national president George Tambassis said in his address to the …

The Pharmaceutical Society of Australia has welcomed the deferral of a final decision on the possible rescheduling of codeine. PSA National President, Joe Demarte says that the extra time allowed …

The deferment of a final decision on the upscheduling of codeine-containing OTCs is very good news, but stakeholders now need to get moving quickly on the proposed real-time monitoring system …

The Pharmacy Guild of Australia has welcomed today’s decision to defer the proposed re-scheduling of medicines containing codeine until 2017, subject to further consideration. The delegate of the Secretary of …

Over-the-counter medicines containing codeine will remain OTC until at least 2017, the TGA has announced. A delegate of the Secretary to the Department of Health gave notice of the deferment …

There’s been a lot of debate on upscheduling codeine, writes Phil Spyrou, but if it happens, pharmacists will have an opportunity to help migraine sufferers The final decision on whether …

Upscheduling codeine-containing OTCs could cost upwards of $1.27 billion in MBS outlay alone over the next four years, a new report has found. The Pharmacy Guild engaged Cadence Economics to …

Professor Peter Carroll, Dr Rebekah Moles, Dr Slade Matthews, Stuart Nankivell and Nick Logan (Members of the NSW Poisons Advisory Committee) on why they think upscheduling combination codeine products is …